Athenex, Inc. (ATNX) Financial Statements (2026 and earlier)

Company Profile

Business Address 1001 MAIN STREET
BUFFALO, NY 14203
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments36,22123,32837,45945,40988,512130,224
Cash and cash equivalent35,18722,13927,22435,20273,59476,941
Short-term investments1,0341,18910,23510,20714,91853,283
Restricted cash and investments5,22513,82513,75016,50016,50016,500
Receivables32,91233,82429,60526,63733,75722,218
Inventory, net of allowances, customer advances and progress billings42,03937,85141,25334,68531,57729,765
Inventory42,03937,85141,25334,68531,57729,765
Disposal group, including discontinued operation6,1844,943 1,280  
Other undisclosed current assets4,1253,9759,5218,88514,49114,384
Total current assets:126,706117,746131,588133,396184,837213,091
Noncurrent Assets
Operating lease, right-of-use asset4,4394,8855,7966,2436,5117,019
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization3,9124,19426,86327,97851,91645,685
Intangible asset, including goodwill, after accumulated amortization72,16872,47271,56771,896141,504141,995
Goodwill     67,61769,216
Intangible asset, excluding goodwill, after accumulated amortization72,16872,47271,56771,89673,88772,779
Disposal group, including discontinued operation, noncurrent assets20,17321,599 26,848  
Other noncurrent assets9529911,0481,0871,1261,167
Total noncurrent assets:101,644104,141105,274134,052201,057195,866
TOTAL ASSETS:228,350221,887236,862267,448385,894408,957
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities73,13167,14653,56341,19563,00355,079
Taxes payable✕1,6781,668✕   
Employee-related liabilities✕6,2994,796✕   
Accounts payable25,07121,39716,60516,74222,87719,467
Accrued liabilities40,08339,28536,95824,45340,12635,612
Debt14,92723,73824,68046,8817,4874,725
Disposal group, including discontinued operation2,7963,674 5,062  
Business combination, contingent consideration, liability      
Other undisclosed current liabilities(5,951)(4,387)2,5412,9093,0443,119
Total current liabilities:84,90390,17180,78496,04773,53462,923
Noncurrent Liabilities
Long-term debt and lease obligation3,5504,0504,4634,7015,1325,741
Finance lease, liability123152180207379424
Liabilities, other than long-term debt30,43036,05928,76528,9995,1355,329
Deferred income tax liabilities1,7511,7511,7511,7511,8171,833
Disposal group, including discontinued operation, liabilities 7,0337,490 126  
Other liabilities2,7092,6892,8673,0463,3183,496
Operating lease, liability3,4273,8984,2834,4944,7535,317
Business combination, contingent consideration, liability18,93724,12924,14724,076  
Other undisclosed noncurrent liabilities102,23197,080102,051103,249166,214165,084
Total noncurrent liabilities:136,211137,189135,279136,949176,481176,154
Total liabilities:221,114227,360216,063232,996250,015239,077
Equity
Equity, attributable to parent24,84511,93537,99051,131151,879185,201
Common stock159119113111111111
Treasury stock, value(7,757)(7,485)(7,485)(7,485)(7,485)(7,485)
Additional paid in capital1,012,114980,819976,119972,404969,315966,666
Accumulated other comprehensive income (loss)2,9871,47175(487)(1,037)(1,123)
Accumulated deficit(982,658)(962,989)(930,832)(913,412)(809,025)(772,968)
Equity, attributable to noncontrolling interest(17,609)(17,408)(17,191)(16,679)(16,000)(15,321)
Total equity:7,236(5,473)20,79934,452135,879169,880
TOTAL LIABILITIES AND EQUITY:228,350221,887236,862267,448385,894408,957

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
Revenues33,53031,51629,72424,93632,29721,923
Cost of revenue
(Cost of Product and Service Sold)		(27,736)(23,092)(23,295)(20,694)(25,644)(19,663)
Gross profit:5,7948,4246,4294,2426,6532,260
Operating expenses(18,652)(30,266)(28,925)(94,096)(40,525)(42,358)
Operating loss:(12,858)(21,842)(22,496)(89,854)(33,872)(40,098)
Nonoperating income
(Investment Income, Nonoperating)		10946772739132
Other undisclosed loss before gain (loss) on sale of properties✕✕✕✕(7,731)✕✕
Interest and debt expense(6,271)(2,256)(8,022)(5,050)(5,100)(5,684)
Loss from continuing operations before equity method investments, income taxes:(19,020)(24,052)(30,441)(94,877)(38,933)(45,650)
Other undisclosed income (loss) from continuing operations before income taxes    (2,459)2,459 
Loss from continuing operations before income taxes:(19,020)(24,052)(30,441)(97,336)(36,474)(45,650)
Income tax expense (benefit)(596)19(28)(15)(262)11,035
Loss from continuing operations:(19,616)(24,033)(30,469)(97,351)(36,736)(34,615)
Loss before gain (loss) on sale of properties:✕(19,870)(32,374)(17,932)(105,082)(36,736)(34,615)
Income (loss) from discontinued operations(254)(8,341)12,537   
Net loss:(19,870)(32,374)(17,932)(105,082)(36,736)(34,615)
Net income attributable to noncontrolling interest201217512695679341
Net loss available to common stockholders, diluted:(19,669)(32,157)(17,420)(104,387)(36,057)(34,274)

Comprehensive Income ($ in thousands)
Annual | Quarterly

12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
Net loss:(19,870)(32,374)(17,932)(105,082)(36,736)(34,615)
Other comprehensive income (loss) 1,5161,396562 86(282)
Other undisclosed comprehensive income   647  
Comprehensive loss:(18,354)(30,978)(17,370)(104,435)(36,650)(34,897)
Comprehensive income, net of tax, attributable to noncontrolling interest201217512695679341
Other undisclosed comprehensive loss, net of tax, attributable to parent   (97)  
Comprehensive loss, net of tax, attributable to parent:(18,153)(30,761)(16,858)(103,837)(35,971)(34,556)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: